Glenmark Life Sciences Ltd Q3 FY2024 PAT at Rs. 118.76 crores

Glenmark Life Sciences Ltd has reported Standalone financial results for the period ended December 31, 2023.

Financial Results (Q3 FY2024) - QoQ Comparison

The company has reported total income of Rs. 574.495 crores during the period ended December 31, 2023 as compared to Rs. 600.732 crores during the period ended September 30, 2023.

The company has posted net profit / (loss) of Rs. 118.765 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs. 118.737 crores for the period ended September 30, 2023.

The company has reported EPS of Rs. 9.67 for the period ended December 31, 2023 as compared to Rs. 9.69 for the period ended September 30, 2023.

Financials	Q3 FY2024	Q2 FY2024	% Change
Total Income	₹ 574.495 crs	₹600.732 crs	-4.37%
Net Profit	₹118.765 crs	₹118.737 crs	0.02%
EPS	₹9.67	₹9.69	-0.21%

Financial Results (Q3 FY2024) - YoY Comparison

The company has reported total income of Rs. 574.495 crores during the period ended December 31, 2023 as compared to Rs.547.339 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs.118.765 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs.104.993 crores for the period ended December 31, 2022.

The company has reported EPS of Rs.9.67 for the period ended December 31, 2023 as compared to Rs.8.57 for the period ended December 31, 2022.

Financials	Q3 FY2024	Q3 FY2023	% Change
Total Income	₹ 574.495 crs	₹547.339 crs	4.96%
Net Profit	₹118.765 crs	₹104.993 crs	13.12%
EPS	₹9.67	₹8.57	12.84%

Financial Results (9 Months Ended FY2024) - YoY Comparison

The company has reported total income of Rs.1755.528 crores during the 9 Months period ended December 31, 2023 as compared to Rs.1566.021 crores during the 9 Months period ended December 31, 2022.

The company has posted net profit / (loss) of Rs.372.952 crores for the 9 Months period ended December 31, 2023 as against net profit / (loss) of Rs.320.604 crores for the 9 Months period ended December 31, 2022.

The company has reported EPS of Rs.30.42 for the 9 Months period ended December 31, 2023 as compared to Rs.26.16 for the 9 Months period ended December 31, 2022.

Financials	9 Months Ended FY2024	9 Months Ended FY2023	% Change
Total Income	₹1755.528 crs	₹1566.021 crs	12.10%
Net Profit	₹372.952 crs	₹320.604 crs	16.33%
EPS	₹30.42	₹26.16	16.28%

Shares of Glenmark Life Sciences Ltd was last trading in BSE at Rs. 792.10 as compared to the previous close of Rs. 798.35. The total number of shares traded during the day was 14777 in over 1233 trades.

The stock hit an intraday high of Rs. 798.35 and intraday low of 776.00. The net turnover during the day was Rs. 11678507.00.

Source : Equity Bulls

Keywords

GlenmarkLifeSciences Q3FY24 9MFY24 ResultUpdate